Satoru Morita, M.B.,B.S., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Aneurysm, False | 4 | 2020 | 276 | 1.210 |
Why?
|
Nephrectomy | 6 | 2021 | 1050 | 1.120 |
Why?
|
Cholangiopancreatography, Magnetic Resonance | 3 | 2009 | 101 | 0.970 |
Why?
|
Anastomotic Leak | 2 | 2022 | 162 | 0.890 |
Why?
|
Hypocapnia | 1 | 2021 | 34 | 0.800 |
Why?
|
Laparoscopy | 3 | 2022 | 2150 | 0.700 |
Why?
|
Contrast Media | 6 | 2020 | 5300 | 0.630 |
Why?
|
Arteriosclerosis | 1 | 2022 | 1092 | 0.590 |
Why?
|
Bile Duct Neoplasms | 1 | 2022 | 567 | 0.580 |
Why?
|
Cholangiocarcinoma | 1 | 2022 | 516 | 0.580 |
Why?
|
Radiographic Image Enhancement | 1 | 2020 | 885 | 0.500 |
Why?
|
Intraoperative Complications | 1 | 2021 | 1198 | 0.480 |
Why?
|
Colorectal Neoplasms | 3 | 2022 | 6773 | 0.440 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2020 | 1184 | 0.440 |
Why?
|
Rectal Neoplasms | 1 | 2022 | 1205 | 0.430 |
Why?
|
Vena Cava, Inferior | 3 | 2013 | 440 | 0.430 |
Why?
|
Cholangiography | 1 | 2012 | 189 | 0.420 |
Why?
|
Postoperative Complications | 3 | 2021 | 15297 | 0.410 |
Why?
|
Surgical Wound Infection | 1 | 2021 | 1540 | 0.400 |
Why?
|
Postoperative Hemorrhage | 1 | 2015 | 412 | 0.390 |
Why?
|
Renal Artery | 3 | 2020 | 399 | 0.370 |
Why?
|
Biliary Tract Diseases | 2 | 2009 | 161 | 0.370 |
Why?
|
Ampulla of Vater | 1 | 2009 | 141 | 0.340 |
Why?
|
Duodenal Diseases | 1 | 2009 | 102 | 0.340 |
Why?
|
Diverticulum | 1 | 2009 | 136 | 0.330 |
Why?
|
Biliary Tract | 1 | 2009 | 134 | 0.320 |
Why?
|
Phlebography | 3 | 2013 | 333 | 0.320 |
Why?
|
Common Bile Duct | 1 | 2008 | 109 | 0.300 |
Why?
|
Drainage | 1 | 2012 | 1142 | 0.290 |
Why?
|
Forced Expiratory Volume | 3 | 2016 | 1745 | 0.260 |
Why?
|
Pancreatic Diseases | 1 | 2008 | 350 | 0.260 |
Why?
|
Embolization, Therapeutic | 1 | 2015 | 1392 | 0.260 |
Why?
|
Airway Resistance | 2 | 2016 | 404 | 0.230 |
Why?
|
Veins | 1 | 2006 | 770 | 0.210 |
Why?
|
Thiamine | 1 | 2023 | 152 | 0.210 |
Why?
|
Imaging, Three-Dimensional | 4 | 2015 | 4042 | 0.210 |
Why?
|
Liver Transplantation | 1 | 2012 | 2119 | 0.200 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2022 | 295 | 0.190 |
Why?
|
Intestinal Mucosa | 2 | 2023 | 3037 | 0.190 |
Why?
|
Vena Cava Filters | 2 | 2013 | 253 | 0.180 |
Why?
|
Magnetic Resonance Angiography | 1 | 2006 | 1443 | 0.180 |
Why?
|
Gangrene | 1 | 2019 | 82 | 0.170 |
Why?
|
Aged, 80 and over | 14 | 2021 | 57776 | 0.170 |
Why?
|
Artifacts | 1 | 2008 | 1904 | 0.170 |
Why?
|
Cholecystitis, Acute | 1 | 2019 | 70 | 0.160 |
Why?
|
Needles | 1 | 2022 | 449 | 0.160 |
Why?
|
Lower Extremity | 1 | 2006 | 1158 | 0.160 |
Why?
|
Anastomosis, Surgical | 1 | 2022 | 987 | 0.160 |
Why?
|
Retrospective Studies | 15 | 2021 | 77460 | 0.160 |
Why?
|
Listeriosis | 1 | 2019 | 149 | 0.150 |
Why?
|
Tomography, X-Ray Computed | 8 | 2022 | 20130 | 0.150 |
Why?
|
Lumbar Vertebrae | 1 | 2006 | 1848 | 0.150 |
Why?
|
Cholecystectomy | 1 | 2019 | 395 | 0.150 |
Why?
|
Ferric Compounds | 2 | 2009 | 374 | 0.140 |
Why?
|
Symbiosis | 1 | 2019 | 287 | 0.140 |
Why?
|
Kidney Neoplasms | 3 | 2021 | 4262 | 0.140 |
Why?
|
Aged | 18 | 2021 | 163288 | 0.130 |
Why?
|
Th1 Cells | 1 | 2020 | 1057 | 0.130 |
Why?
|
Middle Aged | 19 | 2021 | 213390 | 0.120 |
Why?
|
Algorithms | 2 | 2020 | 13882 | 0.120 |
Why?
|
Inhalation | 1 | 2014 | 143 | 0.120 |
Why?
|
Intestine, Small | 1 | 2020 | 1240 | 0.120 |
Why?
|
Vital Capacity | 1 | 2016 | 925 | 0.120 |
Why?
|
Adult | 18 | 2021 | 214052 | 0.120 |
Why?
|
Angiomyolipoma | 1 | 2015 | 190 | 0.120 |
Why?
|
Phantoms, Imaging | 1 | 2022 | 2480 | 0.110 |
Why?
|
Male | 22 | 2022 | 350115 | 0.110 |
Why?
|
Renal Veins | 1 | 2013 | 108 | 0.110 |
Why?
|
Kidney | 3 | 2020 | 7184 | 0.110 |
Why?
|
Carcinoma, Renal Cell | 2 | 2021 | 3143 | 0.110 |
Why?
|
Observer Variation | 2 | 2009 | 2593 | 0.100 |
Why?
|
Asymptomatic Diseases | 1 | 2015 | 551 | 0.100 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2009 | 8949 | 0.100 |
Why?
|
Humans | 27 | 2023 | 744366 | 0.100 |
Why?
|
Radiation Dosage | 1 | 2020 | 1928 | 0.100 |
Why?
|
Female | 21 | 2023 | 380193 | 0.100 |
Why?
|
Risk Factors | 6 | 2022 | 72296 | 0.100 |
Why?
|
Pulmonary Embolism | 2 | 2013 | 2375 | 0.090 |
Why?
|
Glomerular Filtration Rate | 2 | 2015 | 2166 | 0.090 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2022 | 2214 | 0.090 |
Why?
|
Cysts | 1 | 2015 | 678 | 0.090 |
Why?
|
Early Diagnosis | 1 | 2015 | 1184 | 0.090 |
Why?
|
Iatrogenic Disease | 1 | 2013 | 547 | 0.090 |
Why?
|
Vascular System Injuries | 1 | 2013 | 250 | 0.090 |
Why?
|
Cystic Duct | 1 | 2009 | 19 | 0.090 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2022 | 4479 | 0.080 |
Why?
|
Quaternary Ammonium Compounds | 1 | 2009 | 205 | 0.080 |
Why?
|
Prosthesis Implantation | 1 | 2013 | 642 | 0.080 |
Why?
|
Catheterization, Central Venous | 1 | 2013 | 514 | 0.080 |
Why?
|
Fluoroscopy | 1 | 2012 | 924 | 0.080 |
Why?
|
Pulmonary Fibrosis | 1 | 2012 | 530 | 0.080 |
Why?
|
Escherichia coli | 1 | 2020 | 4217 | 0.080 |
Why?
|
Vascular Malformations | 1 | 2013 | 454 | 0.080 |
Why?
|
Bacteria | 1 | 2019 | 2115 | 0.080 |
Why?
|
Image Enhancement | 2 | 2009 | 2921 | 0.080 |
Why?
|
Crohn Disease | 1 | 2020 | 2304 | 0.070 |
Why?
|
Pulmonary Emphysema | 1 | 2012 | 672 | 0.070 |
Why?
|
Fourier Analysis | 1 | 2008 | 447 | 0.070 |
Why?
|
Pulsatile Flow | 1 | 2008 | 332 | 0.070 |
Why?
|
Liver Neoplasms | 1 | 2022 | 4253 | 0.070 |
Why?
|
Time Factors | 2 | 2021 | 40075 | 0.070 |
Why?
|
Lung Diseases, Interstitial | 1 | 2014 | 808 | 0.070 |
Why?
|
Diet | 1 | 2023 | 7937 | 0.060 |
Why?
|
Oscillometry | 2 | 2016 | 147 | 0.060 |
Why?
|
Venous Thrombosis | 1 | 2013 | 1239 | 0.060 |
Why?
|
Motion | 1 | 2008 | 798 | 0.060 |
Why?
|
Trinitrobenzenesulfonic Acid | 1 | 2023 | 68 | 0.060 |
Why?
|
Adipose Tissue | 1 | 2015 | 3280 | 0.060 |
Why?
|
Specific Pathogen-Free Organisms | 1 | 2023 | 226 | 0.060 |
Why?
|
Spirometry | 2 | 2016 | 865 | 0.050 |
Why?
|
Kidney Diseases | 1 | 2013 | 2148 | 0.050 |
Why?
|
Adenocarcinoma | 1 | 2019 | 6364 | 0.050 |
Why?
|
Reproducibility of Results | 2 | 2009 | 19905 | 0.050 |
Why?
|
Treatment Outcome | 4 | 2019 | 63107 | 0.050 |
Why?
|
Young Adult | 5 | 2015 | 56429 | 0.050 |
Why?
|
Punctures | 1 | 2022 | 374 | 0.050 |
Why?
|
Smoking | 1 | 2017 | 8987 | 0.050 |
Why?
|
Chi-Square Distribution | 1 | 2006 | 3508 | 0.050 |
Why?
|
ROC Curve | 2 | 2019 | 3528 | 0.050 |
Why?
|
Sensitivity and Specificity | 2 | 2019 | 14723 | 0.050 |
Why?
|
Interleukin-4 | 1 | 2023 | 1147 | 0.040 |
Why?
|
Technology | 1 | 2022 | 304 | 0.040 |
Why?
|
Respiratory Function Tests | 2 | 2014 | 1617 | 0.040 |
Why?
|
Predictive Value of Tests | 1 | 2015 | 15078 | 0.040 |
Why?
|
Integrin alpha Chains | 1 | 2019 | 97 | 0.040 |
Why?
|
Asthma | 1 | 2016 | 6010 | 0.040 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2012 | 3047 | 0.040 |
Why?
|
Mice | 5 | 2023 | 81201 | 0.040 |
Why?
|
Hospitals, University | 1 | 2019 | 570 | 0.040 |
Why?
|
Organoids | 1 | 2023 | 701 | 0.040 |
Why?
|
Listeria monocytogenes | 1 | 2019 | 250 | 0.040 |
Why?
|
Adrenergic Agonists | 1 | 2016 | 58 | 0.040 |
Why?
|
Regression Analysis | 2 | 2016 | 6459 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2023 | 20824 | 0.030 |
Why?
|
Warm Ischemia | 1 | 2015 | 53 | 0.030 |
Why?
|
Lymphatic Metastasis | 1 | 2023 | 2924 | 0.030 |
Why?
|
Japan | 1 | 2019 | 1360 | 0.030 |
Why?
|
Multivariate Analysis | 2 | 2019 | 12244 | 0.030 |
Why?
|
Immune Tolerance | 1 | 2023 | 2259 | 0.030 |
Why?
|
Tomography Scanners, X-Ray Computed | 1 | 2014 | 168 | 0.030 |
Why?
|
Th17 Cells | 1 | 2020 | 766 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2017 | 13104 | 0.030 |
Why?
|
Feces | 1 | 2019 | 1401 | 0.030 |
Why?
|
Retroperitoneal Space | 1 | 2013 | 176 | 0.030 |
Why?
|
Animals | 5 | 2023 | 168768 | 0.030 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2019 | 1366 | 0.030 |
Why?
|
Angiogenesis Inhibitors | 1 | 2022 | 2038 | 0.030 |
Why?
|
Anti-Asthmatic Agents | 1 | 2016 | 536 | 0.030 |
Why?
|
Emphysema | 1 | 2014 | 247 | 0.030 |
Why?
|
Logistic Models | 1 | 2006 | 13409 | 0.030 |
Why?
|
Lymph Nodes | 1 | 2023 | 3476 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2022 | 3511 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2019 | 3554 | 0.020 |
Why?
|
Interferon-gamma | 1 | 2019 | 3207 | 0.020 |
Why?
|
Angiography | 1 | 2015 | 1639 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2023 | 2988 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2019 | 15535 | 0.020 |
Why?
|
Antigens, CD | 1 | 2019 | 4026 | 0.020 |
Why?
|
Fibrosis | 1 | 2014 | 2029 | 0.020 |
Why?
|
Nitric Oxide | 1 | 2016 | 2132 | 0.020 |
Why?
|
Dendritic Cells | 1 | 2019 | 2725 | 0.020 |
Why?
|
Adrenal Cortex Hormones | 1 | 2016 | 1856 | 0.020 |
Why?
|
Prognosis | 2 | 2019 | 29060 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2017 | 4851 | 0.020 |
Why?
|
Incidence | 2 | 2015 | 20952 | 0.020 |
Why?
|
Sex Factors | 1 | 2019 | 10400 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2017 | 3590 | 0.020 |
Why?
|
Mice, Inbred C57BL | 1 | 2023 | 21833 | 0.020 |
Why?
|
Ultrasonography, Interventional | 1 | 2013 | 1486 | 0.020 |
Why?
|
Databases, Factual | 1 | 2019 | 7730 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2017 | 12356 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2017 | 11031 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2019 | 16690 | 0.010 |
Why?
|
Age Factors | 1 | 2019 | 18373 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2015 | 12961 | 0.010 |
Why?
|
Risk Assessment | 1 | 2019 | 23336 | 0.010 |
Why?
|
Cohort Studies | 1 | 2019 | 40559 | 0.010 |
Why?
|
Child | 2 | 2013 | 77709 | 0.010 |
Why?
|
Adolescent | 2 | 2013 | 85779 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2014 | 25039 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2013 | 39052 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2015 | 35425 | 0.000 |
Why?
|
United States | 1 | 2013 | 69872 | 0.000 |
Why?
|